Filtros de búsqueda

Lista de obras de Lorenza Rimassa

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

artículo científico publicado en 2013

A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer

artículo científico publicado en 2015

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.

artículo científico publicado en 2008

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

artículo científico publicado en 2014

A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study

artículo científico publicado en 2019

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2010

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

artículo científico publicado en 2007

Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival

artículo científico publicado en 2010

Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era

artículo científico publicado en 2018

An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab

artículo científico publicado en 2015

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner

artículo científico publicado en 2020

Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses?

artículo científico publicado en 2007

Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial

artículo científico publicado en 2020

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications

artículo científico publicado en 2016

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial

artículo científico publicado en 2019

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

artículo científico publicado en 2020

Biomarkers in Hepatocellular Carcinoma--Letter

scientific article published on 02 August 2012

Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer

scientific article published on 04 June 2019

CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer

artículo científico publicado en 2019

COVID-19 and liver cancer clinical trials: not everything is lost

scientific article published on 20 May 2020

Cabozantinib for the treatment of hepatocellular carcinoma

artículo científico publicado en 2019

Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

article by Ghassan K Abou-Alfa et al published 5 July 2018 in The New England Journal of Medicine

Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design

artículo científico publicado en 2020

Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib

artículo científico publicado en 2019

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

artículo científico publicado en 2019

Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancer

artículo científico publicado en 2010

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

artículo científico publicado en 2020

Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression

scientific article published on 25 February 2019

Combined PD-1/VEGFR blockade: a new era of treatment for hepatocellular cancer

artículo científico publicado en 2020

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

artículo científico publicado en 2018

Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors

artículo científico publicado en 2011

Diagnostic accuracy of ¹¹C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma.

artículo científico publicado en 2015

Drugs in Development for Hepatocellular Carcinoma

article

Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trial

artículo científico publicado en 2020

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study

scientific article published on 21 March 2018

Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?

artículo científico publicado en 2018

Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram

article

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.

artículo científico publicado en 2015

FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial

article

Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection

scientific article published on 20 June 2011

Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer

artículo científico publicado en 2014

Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study

artículo científico publicado en 2022

Gastric cancer: Translating novels concepts into clinical practice

scientific article published on 14 August 2019

Hepatocellular Carcinoma: A Global Disease in Need of Individualized Treatment Strategies

artículo científico publicado en 2017

Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment

artículo científico publicado en 2016

Hepatotoxicity of immune check point inhibitors: Approach and management

artículo científico publicado en 2019

High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models

artículo científico publicado en 2017

High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients

artículo científico publicado en 2005

Immune-based therapies for hepatocellular carcinoma

artículo científico publicado en 2020

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

scientific article published on 10 July 2020

Immunotherapy in hepatobiliary tumors: search for the missing pieces of the puzzle

scientific article published on 01 February 2020

Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism

artículo científico publicado en 2011

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

artículo científico publicado en 2004

International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

artículo científico publicado en 2020

Irinotecan and raltitrexed: an active combination in advanced colorectal cancer

artículo científico publicado en 2002

Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question

artículo científico publicado en 2019

KRAS mutation in lung metastases from colorectal cancer: prognostic implications

artículo científico publicado en 2015

Khorana score and thromboembolic risk in stage II-III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

artículo científico publicado en 2020

Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT.

artículo científico publicado en 2013

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

article

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

scientific article published on 03 July 2019

Management of adverse events associated with tyrosine kinase inhibitors: Improving outcomes for patients with hepatocellular carcinoma

scientific article published on 15 May 2019

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

artículo científico publicado en 2014

Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells

artículo científico publicado en 2019

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.

artículo científico publicado en 2013

Molecular therapies for HCC: Looking outside the box

scientific article published on 01 February 2020

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

artículo científico publicado en 2021

Navigating the new landscape of second-line treatment in advanced hepatocellular carcinoma

scientific article published on 20 May 2020

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

scientific article published on 20 September 2019

Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells

scientific article published on 18 February 2019

Novel Therapies for Hepatocellular Carcinoma

artículo científico publicado en 2020

Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib

artículo científico publicado en 2011

Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer

artículo científico publicado en 1995

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

artículo científico publicado en 2012

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

artículo científico publicado en 2019

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

artículo científico publicado en 2010

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

scientific article published on 01 August 2020

Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis

artículo científico publicado en 2020

Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial

artículo científico publicado en 2020

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

artículo científico publicado en 2008

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

artículo científico publicado en 2016

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

artículo científico publicado en 2017

Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?

artículo científico publicado en 2018

Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.

artículo científico publicado en 2018

Rectal squamous cell carcinoma treated with chemoradiotherapy: report of six cases

artículo científico publicado en 2010

Regorafenib for the treatment of unresectable hepatocellular carcinoma.

artículo científico

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications.

artículo científico publicado en 2018

Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND)

scientific article published on 20 November 2019

SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

artículo científico publicado en 2013

Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2-3 trial.

artículo científico publicado en 2018

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma

scientific article published on 17 June 2020

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study

scientific article published on 11 December 2018

Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.

artículo científico publicado en 2017

Serum Markers of Bone Metastases in Postmenopausal Breast Cancer Patients Treated with Formestane

artículo científico publicado el 1 de enero de 1997

Serum alpha-fetoprotein levels and clinical outcome in the phase 3 CELESTIAL study of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma

scientific article published on 07 July 2020

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

artículo científico publicado en 2016

Shaping the landscape of immune oncology in hepatocellular carcinoma

artículo científico publicado en 2018

Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!

artículo científico publicado en 2017

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

article

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

artículo científico publicado en 2009

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

artículo científico publicado en 2014

Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis

artículo científico publicado en 2018

Systemic Treatment Options in Hepatocellular Carcinoma

artículo científico publicado en 2019

Targeted agents for second-line treatment of advanced hepatocellular carcinoma

scientific article published on 01 October 2019

The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study

artículo científico publicado en 2007

The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine

artículo científico publicado en 2019

The present and the future landscape of treatment of advanced hepatocellular carcinoma.

artículo científico publicado en 2010

The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer.

artículo científico publicado en 2012

Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--letter

artículo científico publicado en 2013

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

article

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

artículo científico publicado en 2012

Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers.

artículo científico publicado en 2015

Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma

artículo científico publicado en 2013

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

artículo científico publicado en 2017

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

artículo científico publicado en 2016

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.

artículo científico publicado en 2017

Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.

artículo científico publicado en 2017

Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC

scientific article published on 07 April 2020

Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer

artículo científico publicado en 2003

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

artículo científico publicado en 2012

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma

scientific article published on 29 January 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda